Taha Azad Ottawa Hospital Research Institute Biography Publications Institution JoVE Articles Taha Azad has not added a biography. If you are Taha Azad and would like to personalize this page please email our Author Liaison for assistance. Publications Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein Journal of Medicinal Chemistry. Jul, 2021 | Pubmed ID: 34328726 A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion Nanomaterials (Basel, Switzerland). Mar, 2021 | Pubmed ID: 33809836 SARS-CoV-2 S1 NanoBiT: A Nanoluciferase Complementation-based Biosensor to Rapidly Probe SARS-CoV-2 Receptor Recognition Biosensors & Bioelectronics. May, 2021 | Pubmed ID: 33706157 Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction International Journal of Molecular Sciences. Feb, 2021 | Pubmed ID: 33668756 Nanoluciferase Complementation-based Bioreporter Reveals the Importance of N-linked Glycosylation of SARS-CoV-2 S for Viral Entry Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2021 | Pubmed ID: 33578036 Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization Membranes. Aug, 2020 | Pubmed ID: 32872641 Hippo Signaling Pathway As a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis Cancers. Jul, 2020 | Pubmed ID: 32722184 TAZ Enhances Mammary Cell Proliferation in 3D Culture Through Transcriptional Regulation of IRS1 Cellular Signalling. Aug, 2018 | Pubmed ID: 30138697 PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways Molecular Cancer Research : MCR. Jun, 2018 | Pubmed ID: 29545474 The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer Through PD-L1 Cancer Research. Mar, 2018 | Pubmed ID: 29339539 Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter Reza Rezaei1,2, Abera Surendran1,2, Ragunath Singaravelu1,2, Taylor R. Jamieson1,2, Parisa Taklifi3, Joanna Poutou1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 3Department of Biotechnology, University of Tehran JoVE 62488 Immunologie et Infection Nachweis von SARS-CoV-2 neutralisierenden Antikörpern mittels Hochdurchsatz-Fluoreszenzbildgebung von Pseudovirus-Infektionen Taylor R. Jamieson1,2, Joanna Poutou1,2, Ricardo Marius1,2, Xiaohong He1, Reza Rezaei1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa JoVE 62486 Immunologie et Infection Überwachung von Hippo Signalisierung Pathway-Aktivität unter Verwendung eines Biosensors Luciferase-basierte großen Tumorsuppressor (LATS) Taha Azad*1, Kazem Nouri*1, Helena J. Janse van Rensburg1, Yawei Hao1, Xiaolong Yang1 1Department of Pathology and Molecular Medicine, Queen's University JoVE 58416 Recherche en cancérologie
Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter Reza Rezaei1,2, Abera Surendran1,2, Ragunath Singaravelu1,2, Taylor R. Jamieson1,2, Parisa Taklifi3, Joanna Poutou1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 3Department of Biotechnology, University of Tehran JoVE 62488 Immunologie et Infection
Nachweis von SARS-CoV-2 neutralisierenden Antikörpern mittels Hochdurchsatz-Fluoreszenzbildgebung von Pseudovirus-Infektionen Taylor R. Jamieson1,2, Joanna Poutou1,2, Ricardo Marius1,2, Xiaohong He1, Reza Rezaei1,2, Taha Azad1,2, Carolina S. Ilkow1,2 1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa JoVE 62486 Immunologie et Infection
Überwachung von Hippo Signalisierung Pathway-Aktivität unter Verwendung eines Biosensors Luciferase-basierte großen Tumorsuppressor (LATS) Taha Azad*1, Kazem Nouri*1, Helena J. Janse van Rensburg1, Yawei Hao1, Xiaolong Yang1 1Department of Pathology and Molecular Medicine, Queen's University JoVE 58416 Recherche en cancérologie